SCHEMBL22308954

SCHEMBL22308954

C=C/C(=C\C=C/C)c1nc(-c2cccc(-c3cccc(-c4cc(-c5cccc(-c6ccccc6)c5)nc(-c5ccccc5)n4)c3)c2)nc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.37
▸ KMT2A Q03164 8/20 0.37
▸ ALDH1A1 P00352 6/20 0.37
▸ MAPT P10636 6/20 0.37
▸ HPGD P15428 6/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ NTSR1 P30989 1/20 0.35
▸ MAOB P27338 3/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ MAOA P21397 2/20 0.32
▸ KMO O15229 2/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22309943 0.86 MEN1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21574705 0.86 L3MBTL1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19313697 0.84 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24115583 0.83 L3MBTL1 (0.37) MEN1KMT2AMAPTHPGDKDM4E
SCHEMBL22812707 0.83 L3MBTL1 (0.33) MEN1KMT2ALMNA
SCHEMBL19413586 0.82 L3MBTL1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL27250303 0.82 EGFR (0.35) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22762113 0.82 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22373755 0.80 KMO (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL27288432 0.79 ALOX5 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885ALDH1A1 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback